Autopsy report · NCT03960242

Evaluation of Clinical Progression in Patients With Motor Predominant Parkinson Disease.

“Programs strategy refining due to Covid crisis”

The sponsor’s own words in the registry.

Life of this trial

• Registered 4 months after it had already started.
• Ran for about 2 years 3 months before it stopped.
• 3 participants enrolled.
• No results are posted on the registry.

Vital statistics

Status

Terminated

Sponsor

BrainEver

Sponsor type

Industry

Conditions

Parkinson Disease

Participants

3

Sites

2

Countries

France

Trials that died the same way

• A Personalized Prehabilitation Intervention In Elective Joint Replacement Surgery
  “Covid-19 Crisis” (70% match in meaning)
• Diversion Device With Breath Control
  “COVID and no plans to move forward” (65% match in meaning)
• RES Prepared With RECELL® Compared to Conventional Care for Healing of Donor Sites in Ages 1-16 Years
  “Study closed in response to COVID-19 and overall program objectives.” (63% match in meaning)
• LUMIER² Study : LUpus Molecular Immunomonitoring to Evaluate the Risk of Relapse
  “COVID situation” (61% match in meaning)
• A Comparison of Stryker's Tritanium Posterior Lumbar Cage and PEEK Implant
  “Due to COVID-19 disruption” (60% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.